High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Further improvement of outcome in childhood acute lymphoblastic leukemia could be achieved by identifying additional high-risk patients who may benefit from intensified treatment. We earlier identified PTPRC (CD45) gene expression as a potential new stratification marker and now analyzed the prognos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cario, Gunnar, Rhein, Peter, Mitlöhner, Rita, Zimmermann, Martin, Bandapalli, Obul R., Romey, Renja, Moericke, Anja, Ludwig, Wolf-Dieter, Ratei, Richard, Muckenthaler, Martina U., Kulozik, Andreas E., Schrappe, Martin, Stanulla, Martin, Karawajew, Leonid
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2014
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007934/
https://ncbi.nlm.nih.gov/pubmed/23911702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.090225
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars